Contract 75N95019P00592
Medchemexpress Llc · Department Of Health And Human Services · September 5, 2019
Medchemexpress Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 5, 2019 for $77,000 of work in biological product (except diagnostic) manufacturing. Performance is in Princeton, NJ. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 30, 2024.
Contract details
- PIID
- 75N95019P00592
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Princeton, NJ
- First action
- September 5, 2019
- Latest action
- January 30, 2024
Description
BIOACTIVE COMPOUND LIBRARY
Modification timeline
-
January 30, 2024Mod P00002$-456
-
June 9, 2022Mod P00001$0
-
September 5, 2019Base award$77.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95019P00592?
Contract 75N95019P00592 is a federal contract awarded to Medchemexpress Llc by Department Of Health And Human Services on September 5, 2019 for $77,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N95019P00592?
Medchemexpress Llc won contract 75N95019P00592 from Department Of Health And Human Services.
How much is contract 75N95019P00592 worth?
Contract 75N95019P00592 has obligated $77,000 to date.